Literature DB >> 10889188

Epidermal growth factor-mediated caveolin recruitment to early endosomes and MAPK activation. Role of cholesterol and actin cytoskeleton.

A Pol1, A Lu, M Pons, S Peiró, C Enrich.   

Abstract

The endocytic compartment of eukaryotic cells is a complex intracellular structure involved in sorting, processing, and degradation of a great variety of internalized molecules. Recently, the uptake through caveolae has emerged as an alternative internalization pathway, which seems to be directly related with some signal transduction pathways. However, the mechanisms, molecules, and structures regulating the transport of caveolin from the cell surface into the endocytic compartment are largely unknown. In this study, normal quiescent fibroblasts (normal rat kidney (NRK)) were used to demonstrate that epidermal growth factor causes partial redistribution of caveolin from the cell surface into a cellubrevin early endocytic compartment. Treatment of NRK cells with cytochalasin D or latrunculin A inhibits this pathway and the concomitant activation of Mek and mitotic-activated protein (MAP) kinase; however, if cells were pre-treated with filipin, cytochalasin D does not inhibit the phosphorylation of MAP kinase induced by epidermal growth factor. From these results we conclude that in NRK cells the intact actin cytoskeleton is necessary for the EGF-mediated transport of caveolin from the cell surface into the early endocytic compartment and the activation of MAP kinase pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889188     DOI: 10.1074/jbc.M001131200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Endocytosis, actin cytoskeleton, and signaling.

Authors:  Jozef Samaj; Frantisek Baluska; Boris Voigt; Markus Schlicht; Dieter Volkmann; Diedrik Menzel
Journal:  Plant Physiol       Date:  2004-07       Impact factor: 8.340

Review 2.  Endothelial membrane reorganization during leukocyte extravasation.

Authors:  Natalia Reglero-Real; Beatriz Marcos-Ramiro; Jaime Millán
Journal:  Cell Mol Life Sci       Date:  2012-05-10       Impact factor: 9.261

Review 3.  Regulation of senescence traits by MAPKs.

Authors:  Carlos Anerillas; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Geroscience       Date:  2020-04-16       Impact factor: 7.713

4.  Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis.

Authors:  Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Takako Tabata; Lenore Pereira
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

5.  Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta.

Authors:  Ekaterina Maidji; Olga Genbacev; Hsin-Ti Chang; Lenore Pereira
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

6.  Differential functions of ApoER2 and very low density lipoprotein receptor in Reelin signaling depend on differential sorting of the receptors.

Authors:  Sarah Duit; Harald Mayer; Sophia M Blake; Wolfgang J Schneider; Johannes Nimpf
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

7.  Calmodulin regulates intracellular trafficking of epidermal growth factor receptor and the MAPK signaling pathway.

Authors:  Francesc Tebar; Priam Villalonga; Tatiana Sorkina; Neus Agell; Alexander Sorkin; Carlos Enrich
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

8.  A role for ion channels in glioma cell invasion.

Authors:  Michael B McFerrin; Harald Sontheimer
Journal:  Neuron Glia Biol       Date:  2006-02

9.  Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol.

Authors:  Lyne Labrecque; Isabelle Royal; David S Surprenant; Cam Patterson; Denis Gingras; Richard Béliveau
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

10.  LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement.

Authors:  Namratha G Sastry; Xuechao Wan; Tianzhi Huang; Angel A Alvarez; Rajendra P Pangeni; Xiao Song; Charles David James; Craig M Horbinski; Cameron W Brennan; Ichiro Nakano; Bo Hu; Shi-Yuan Cheng
Journal:  Neuro Oncol       Date:  2020-09-29       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.